Skip to content
Use caution Drug recall · FDA · Published May 17, 2024

Tivicay PD Recall: Incorrect Expiration Date on Carton

GlaxoSmithKline recalls Tivicay PD 5mg tablets because the carton expiration date (May 2026) does not match the bottle label (April 2025).

🇺🇸 FDA recall #D-0544-2024DrugTivicay ›
Take action

Contact the company

Recalling firmGlaxoSmithKline LLC1011 N Arendell Ave · Zebulon, NC 27597-2309
✎ GovInfoNow plain-language explainer

What happened, in plain English

GlaxoSmithKline LLC is recalling specific cartons of Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension due to a labeling error. The outer carton displays an incorrect expiration date of May 2026, while the correct expiration date on the bottle label is April 2025. This discrepancy affects 463 cartons distributed nationwide within the United States. Read more at govinfonow.com/recall/32663-tivicay-pd-recall-incorrect-expiration-date-on-carton.

Source Summary by GovInfoNow · govinfonow.com/recall/32663-tivicay-pd-recall-incorrect-expiration-date-on-carton · Updated October 9, 2026 · FDA enforcement record: FDA #D-0544-2024

Cite this page

“Tivicay PD Recall: Incorrect Expiration Date on Carton.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/32663-tivicay-pd-recall-incorrect-expiration-date-on-carton. Based on FDA recall #D-0544-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0544-2024%22&limit=1).

Why it’s dangerous

The hazard is a labeling inconsistency where the carton's expiration date (May 2026) is later than the actual product expiration date found on the bottle label (April 2025). This could lead users to believe the medication is safe to use after its true expiration date has passed. The record does not state that the medication itself is unsafe or ineffective, only that the labeling is incorrect.

Who’s affected

Patients who have purchased or been prescribed Tivicay PD 5mg tablets in 60-count bottles from this specific recall lot. The risk is primarily for those relying on the carton date to determine if their medication is expired.

How to tell if you have this one

Check your Tivicay PD carton for an NDC of 49702-255-37 and Lot # AG4M. Look for a labeled expiry date on the carton of May 2026 (or 2026-MAY) while the bottle inside shows an expiration of April 2025 (or 04/2025). The product contains 60 tablets per bottle, along with a 30-mL dosing cup and a 10-mL oral dosing syringe.

  • Brand
    Tivicay
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Carton

    Compare the expiration date on the outer carton against the date on the bottle label to identify if they differ as described in the recall.

  2. Contact Healthcare Provider

    Speak with your pharmacist or doctor to determine if you need a replacement for this specific lot, as no remedy is currently stated in the record.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 8 months after the firm started it.

1. Firm started the recall: May 17, 202412. FDA classified it Class III: Jun 6, 202423. Published in FDA’s Enforcement Report: Jun 12, 202434. FDA terminated the recall: Jan 29, 2025420242025
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0544-2024 (May 17, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0544-2024 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA